ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

N Colombo; C Creutzberg; F Amant; T Bosse; A González-Martín; J Ledermann; C Marth; R Nout; D Querleu; M R Mirza; C Sessa; ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group

doi:10.1093/annonc/mdv484

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

Ann Oncol. 2016 Jan;27(1):16-41. doi: 10.1093/annonc/mdv484. Epub 2015 Dec 2.

Authors

Collaborators

ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group:
M Abal, O Altundag, F Amant, Antoni van Leeuwenhoek, S Banerjee, T Bosse, A Casado, L C de Agustín, D Cibula, N Colombo, C Creutzberg, J-M del Campo, G Emons, F Goffin, A González-Martín, S Greggi, C Haie-Meder, D Katsaros, V Kesic, C Kurzeder, S Lax, F Lécuru, J Ledermann, T Levy, D Lorusso, J Mäenpää, C Marth, X Matias-Guiu, P Morice, H W Nijman, R Nout, M Powell, D Querleu, M R Mirza, N Reed, A Rodolakis, H Salvesen, J Sehouli, C Sessa, A Taylor, A Westermann, A G Zeimet

Affiliations

¹ Division of Medical Gynecologic Oncology, European Institute of Oncology and University of Milan-Bicocca, Milan, Italy clinicalguidelines@esmo.org.
² Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.
³ Department of Gynecological Oncology, University Hospital Leuven, Leuven, Belgium Center for Gynecological Oncology Amsterdam (CGOA), Antoni van Leeuwenhoek, Amsterdam.
⁴ Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
⁵ Department of Medical Oncology, GEICO Cancer Center, Madrid Department of Medical Oncology, MD Anderson Cancer Center, Madrid, Spain.
⁶ Department of Oncology and Cancer Trials, UCL Cancer Institute, London, UK.
⁷ Department of Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria.
⁸ Department of Radiotherapy, Leiden University Medical Center, Leiden, The Netherlands.
⁹ Department of Surgery, Institut Bergonié, Bordeaux, France Department of Gynecology and Obstetrics, McGill University Health Centre, Montreal, Canada.
¹⁰ Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
¹¹ Department of Medical Oncology, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.

PMID: 26634381
DOI: 10.1093/annonc/mdv484

Abstract

The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy & Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on endometrial cancer was held on 11-13 December 2014 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of endometrial cancer. Before the conference, the expert panel prepared three clinically relevant questions about endometrial cancer relating to the following four areas: prevention and screening, surgery, adjuvant treatment and advanced and recurrent disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. Results of this consensus conference, together with a summary of evidence supporting each recommendation, are detailed in this article. All participants have approved this final article.

Keywords: adjuvant; consensus; endometrial neoplasms; practice guideline; surgery; treatment.

Publication types

Consensus Development Conference
Research Support, Non-U.S. Gov't

MeSH terms

Combined Modality Therapy
Early Detection of Cancer
Endometrial Neoplasms / diagnosis*
Endometrial Neoplasms / therapy
Female
Follow-Up Studies
Humans
Mass Screening
Practice Guidelines as Topic